Bracco Imaging Announces Strategic Investment in PHS Technologies Group
|
By HospiMedica International staff writers Posted on 05 Apr 2017 |
|
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.
Bracco’s product and solution portfolio comprises all key diagnostic imaging modalities, along with various medical devices and advanced administration systems for contrast imaging products in the fields of radiology. PHS Technologies Group offers advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines, while increasing efficiency and reducing cost.
Bracco’s strategic investment in PHS Technologies Group aims at expanding its portfolio of software applications for dose management to provide healthcare organizations with the information required to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level. The agreement also strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE], a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities.
"We are pleased to reinforce our partnership with PHS Technologies," said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. "The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring."
"PHS Technologies Group is excited to expand its relationship with Bracco," said Mike Battin, Chief Operating Officer of PHS Technologies Group. "PHS is the OEM manufacturer for Bracco's NEXO[DOSE] product and will implement an expanded service and support offerings to the new markets. Furthermore, PHS will provide significant functional improvements to the application portfolio over the next 24 months."
Bracco’s product and solution portfolio comprises all key diagnostic imaging modalities, along with various medical devices and advanced administration systems for contrast imaging products in the fields of radiology. PHS Technologies Group offers advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines, while increasing efficiency and reducing cost.
Bracco’s strategic investment in PHS Technologies Group aims at expanding its portfolio of software applications for dose management to provide healthcare organizations with the information required to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level. The agreement also strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE], a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities.
"We are pleased to reinforce our partnership with PHS Technologies," said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. "The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring."
"PHS Technologies Group is excited to expand its relationship with Bracco," said Mike Battin, Chief Operating Officer of PHS Technologies Group. "PHS is the OEM manufacturer for Bracco's NEXO[DOSE] product and will implement an expanded service and support offerings to the new markets. Furthermore, PHS will provide significant functional improvements to the application portfolio over the next 24 months."
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Glucose Meter
StatStrip®
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
